# Acceptability and Gastrointestinal Tolerance of a High-Sn-2 Infant Formula

> **NCT02598817** · — · COMPLETED · sponsor: **Société des Produits Nestlé (SPN)** · enrollment: 276 (actual)

## Conditions studied

- Infant Term Birth

## Interventions

- **OTHER:** Standard Infant Formula

## Key facts

- **NCT ID:** NCT02598817
- **Lead sponsor:** Société des Produits Nestlé (SPN)
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-01
- **Primary completion:** 2020-01-08
- **Final completion:** 2021-01-05
- **Target enrollment:** 276 (ACTUAL)
- **Last updated:** 2023-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02598817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02598817, "Acceptability and Gastrointestinal Tolerance of a High-Sn-2 Infant Formula". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02598817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*